Wanted: A study with omalizumab to determine the role of IgE-mediated pathways in atopic dermatitis
- 30 September 2006
- journal article
- other
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 55 (3), 540-541
- https://doi.org/10.1016/j.jaad.2006.01.037
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Failure of omalizumab for treatment of severe adult atopic dermatitisJournal of the American Academy of Dermatology, 2005
- The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammationJournal of Allergy and Clinical Immunology, 2005
- Omalizumab-induced reductions in mast cell FcεRI expression and functionJournal of Allergy and Clinical Immunology, 2004
- Effect of omalizumab in health care workers with occupational latex allergyJournal of Allergy and Clinical Immunology, 2004
- Effect of Omalizumab on Symptoms of Seasonal Allergic RhinitisA Randomized Controlled TrialJama-Journal Of The American Medical Association, 2001
- Treatment of Allergic Asthma with Monoclonal Anti-IgE AntibodyThe New England Journal of Medicine, 1999